Development and application of a dual isotopic labeling method for enhanced detection and quantification of stimulants in urine samples using high-resolution mass spectrometry
- PMID: 39455440
- DOI: 10.1007/s00216-024-05612-2
Development and application of a dual isotopic labeling method for enhanced detection and quantification of stimulants in urine samples using high-resolution mass spectrometry
Abstract
Given the critical nature of anti-doping efforts, the detection of stimulant substances is shifting from accurate qualitative analysis to precise quantitative analysis. Additionally, the use of liquid chromatography-high-resolution mass spectrometry (LC-HRMS) in detecting stimulants is becoming more widespread. However, the lack of isotope-labeled internal standards is causing increasing issues with quantitative accuracy. Furthermore, challenges such as the mass spectrometric response of small molecules and the separation of isomers present additional difficulties. We have developed a quantitative method for stimulant substances containing amine or phenol hydroxyl groups, using a dual-label derivatization system. This method offers a new perspective for analyzing and detecting low molecular weight substances, isomers, or those with poor LC-MS response, and proposes a solution to the problem of missing isotope-labeled internal standards. Methodological validation has shown that this approach has promising application potential.
Keywords: Dual isotopic labeling; High-resolution mass spectrometry (HRMS); LC–MS response enhancement; Quantitative analysis; Stimulant detection.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature.
Conflict of interest statement
Declarations. Ethics approval and consent to participate: The study was approved by the ethics committee of Shanghai University of Sport (no. 102772023RT163). Before the experiment started, all participants had detailed procedures introduced and signed informed consent documents. Competing interests: The authors declare no competing interests.
References
-
- Cadwallader AB, de la Torre X, Tieri A, Botrè F. The abuse of diuretics as performance-enhancing drugs and masking agents in sport doping: pharmacology, toxicology and analysis. Br J Pharmacol. 2010;161:1–16. https://doi.org/10.1111/j.1476-5381.2010.00789.x . - DOI - PubMed - PMC
-
- Ljungqvist A. The fight against doping is a fight for the protection of the clean athlete, the health of the athlete and the integrity of sport. Br J Sports Med. 2014;48:799. https://doi.org/10.1136/bjsports-2014-093654 . - DOI - PubMed
-
- 2024list_en_final_22_september_2023.pdf (n.d.) https://www.wada-ama.org/sites/default/files/2023-09/2024list_en_final_2... . Accessed 6 Jul 2024
-
- Stohs SJ, Shara M, Ray SD. p-Synephrine, ephedrine, p-octopamine and m-synephrine: comparative mechanistic, physiological and pharmacological properties. Phytother Res. 2020;34:1838–46. https://doi.org/10.1002/ptr.6649 . - DOI - PubMed - PMC
-
- Goss AJ, Kaser M, Costafreda SG, Sahakian BJ, Fu CHY. Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials. J Clin Psychiatry. 2013;74:1101–7. https://doi.org/10.4088/JCP.13r08560 . - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources